Purified anti-mouse Ly-6G Antibody

Pricing & Availability
1A8 (See other available formats)
Other Names
Lymphocyte antigen 6 complex, locus G
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
C57BL/6 bone marrow cells stained with 1A8 purified, followed by anti-rat IgG PE (myeloid cells were gated for analysis)
  • 1-1A8_Pure_061708.jpg
    C57BL/6 bone marrow cells stained with 1A8 purified, followed by anti-rat IgG PE (myeloid cells were gated for analysis)
  • 2-1A8_Purified_Ly-6G_Antibody_IHC_102518
    Fresh, frozen mouse spleen was stained with purified Ly6G clone 1A8 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
  • 3-1A8_Purified_Ly-6G_Antibody_IHC_022013
    Mouse uterine tissue fixed in 10% formalin, paraffin embedded, and sliced to 4 µm. After deparaffination and antigen retrieval, sample was stained using an automatic slide stainer. The anti-mouse Ly6G primary antibody was applied at 1:500 dilution in blocking buffer for 1 hr at RT and DAB was used for visualization.
Cat # Size Price Quantity Avail. Save
127601 50 µg 44€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
127602 500 µg 92€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Antibody Type
Host Species
Ly-6G transfected EL-4J cell line.
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
The antibody was purified by affinity chromatography.
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.

FC - Quality tested
IHC-F - Verified
IHC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, and depletion4, 12-14. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 127620). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 127632) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Watanabe K, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006513. PubMed
  3. Danobeitia J, et al. 2017. PLoS One.. 10.1371/journal.pone.0183701. PubMed
  4. Nakamizo S,et al. 2017. Sci Rep. . 10.1038/s41598-017-14292-1. PubMed
  5. Bonnart C, et al. 2017. Parasite Immunol.. 10.1111/pim.12489. PubMed
  6. Maybin JA, et al. 2018. Nat Commun. 9:295. PubMed
  7. Meers GK, et al. 2018. PLoS One. 13:e0190846. PubMed
  8. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
  9. Qu S, et al. 2018. Int J Cancer. 8:6685. PubMed
  10. Vallelian F, et al. 2018. Pharmacol Res Perspect. 15:5422. PubMed
  11. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  12. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  13. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  14. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  15. Wang B et al. 2018. Cell stem cell. 22(2):206-220 . PubMed
  16. Bence Daniel et al. 2018. Immunity. 49(4):615-626 . PubMed
  17. Scutts SR, et al. 2018. Cell Rep. 25:1953. PubMed
  18. Otxoa–de–Amezaga A, et al. 2019. Acta Neuropathol. 137:321. PubMed
  19. Simon N, et al. 2019. JCI Insight. 4:. PubMed
  20. Perdomo J, et al. 2019. Nat Commun. 10:1322. PubMed
  21. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  22. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  23. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  24. Boeckel SRV, et al. 2019. Sci Rep. 9:7356. PubMed
  25. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  26. Bianchi–Frias D, et al. 2019. Mol Cancer Res. 17:321. PubMed
  27. Lin L, et al. 2018. J Invest Dermatol. 138:1032. PubMed
  28. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  29. Chudnovskiy A et al. 2016. Cell. 167(2):444-456 . PubMed
  30. Mottahedin A, et al. 2017. J Leukoc Biol. 101:297. PubMed
  31. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  32. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  33. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  34. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  35. Goel S, et al. 2017. Nature. 548:471. PubMed
  36. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  37. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  38. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  39. Schmid AS, et al. 2018. Rheumatology (Oxford). 57:748. PubMed
  40. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  41. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  42. Shen S, et al. 2018. Front Immunol. 1.06875. PubMed
  43. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  44. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  45. Luo J, et al. 2019. Clin Cancer Res. 25:808. PubMed
  46. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  47. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  48. Zhang M, et al. 2018. Front Immunol. 2.285416667. PubMed
  49. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  50. Ford J, et al. 2019. Front Immunol. 2.502083333. PubMed
  51. Kapellos TS, et al. 2019. FASEB J. 33:6154. PubMed
  52. Otxoa–de–Amezaga A, et al. 2019. Stroke. 50:1548. PubMed
  53. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  54. Carper MB, et al. 2019. Cell Rep. 29:1660. PubMed
  55. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  56. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  57. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  58. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  59. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  60. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  61. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  62. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  63. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  64. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  65. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  66. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  67. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  68. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  69. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  70. Peterson LW, et al. 2017. J Exp Med. 214:3171. PubMed
  71. McArthur S, et al. 2020. J Clin Invest. 130:1156. PubMed
  72. Jung H, et al. 2019. Autophagy. 15:1990. PubMed
  73. Rehm SRT, et al. 2019. Sci Rep. 9:9925. PubMed
  74. Yao W, et al. 2019. Nature. 568:410. PubMed
  75. Prows DR, et al. 2020. American Journal of Physiology-Heart and Circulatory Physiology. 317(2):H405-H414.. PubMed
  76. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  77. Choudhury SR, et al. 2020. Cell. 178(5):1205-1221.e17.. PubMed
  78. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  79. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  80. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  81. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  82. Guiducci C, et al. 2010. J Exp Med. 207:2931. PubMed
  83. Sumagin R, et al. 2010. J Immunol. 185:7057. PubMed
  84. Reeves R 2010. J Immunol. 185:4904. PubMed
  85. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  86. Cain D, et al. 2011. PLoS One. 6:e19957. PubMed
  87. Raccosta L, et al. 2013. J Exp Med. 210:1711. PubMed
  88. Andrade E, et al. 2013. J Immunol. 191:4759. PubMed
  89. Ng L, et al. 2011. J Invest Dermatol. 131:2058. PubMed
  90. McCartney-Francis N, et al. 2014. J Leukoc Biol. 96:917. PubMed
  91. Her Z, et al. 2015. EMBO Mol Med. 7:24. PubMed
  92. Ilyas G, et al. 2015. J Hepatol. Available online 29 August 2015. PubMed
  93. Yago T, et al. 2015. J Exp Med. 212: 1267 - 1281. PubMed
  94. Sacramento L, et al. 2015. Infect Immun . 83: 4604 - 4616. PubMed
  95. Stempel H, et al. 2016. J Biol Chem. 291: 9762-9775. PubMed
  96. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  97. Lalazar G, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G377 - G386. PubMed
AB_1089179 (BioLegend Cat. No. 127601)
AB_1089180 (BioLegend Cat. No. 127602)

Antigen Details

A 21-35 kD GPI-anchorded membrane protein

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 6    Revision Date: 10/25/2018

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.


*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.


BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Insert Note Here
Save Close Clear
Lab Timer
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account